Chris Nüesch

Chris has deep expertise addressing client questions across the specialty disease space including rare disease, respiratory, oncology, and cell & gene therapy. Notable work includes the stand-up of a health system engagement strategy for a portfolio of specialty products, and the brand and marketing strategy for a series of indication expansions for a solid tumor oncology agent.  

His project work is often data-driven, either through the analysis of patient-level claims data or through the application of robust primary market research approaches.  

Prior to joining CRA, Chris held a series of progressive roles at leading life sciences strategy consulting firms. Chris holds a bachelor’s degree in Biology from the University of Pennsylvania, an MA in Biology from Columbia University, and an MBA in Finance from the NYU Stern School of Business.